[ACX 2026] Will the US, UK or EU approve a gene editing therapy for a new condition during 2026?
3
100Ṁ121Dec 31
20%
chance
1H
6H
1D
1W
1M
ALL
Resolves according to Metaculus resolution.
Metaculus high-level description:
This question will resolve as Yes if any of the US FDA, UK MHRA, or the EU Commission authorizes the use or sale of a therapy whose primary mechanism directly editing the patient's genomic DNA for any human condition other than sickle cell disease and beta thalassemia before January 1, 2027.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
When will commercial gene-editing therapy be available?
2041
By 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
18% chance
Will any medication be approved for Long Covid/PASC in any Western country before 2026?
Where will human germline gene editing resulting in a live birth first occur legally?
[Metaculus] Before 2032, will a vaccine against HIV-1 be approved by the USA, UK, EU, or Canada?
76% chance
Will we have gene therapy for a major strain of Crohn's disease by 2030?
26% chance
Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?
Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?
59% chance
[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
19% chance
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
79% chance